| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8790478 | American Journal of Ophthalmology | 2018 | 14 Pages |
Abstract
In ranibizumab-treated eyes with NVAMD, more MA lesions develop within the region of baseline CNV (type 1, CNV-based MA) than outside (type 2, CNV-independent MA). Baseline-MA also tends to be located within regions of CNV in the pretreatment phase.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Nizar Saleh Abdelfattah, Amir H. Hariri, Mayss Al-Sheikh, Sean Pitetta, Adel Ebraheem, Charles C. Wykoff, SriniVas R. Sadda,